Latest
Hot
On April 11, Veru (VERU) — soared 24.8% in pre-market trading,after the company reported 'overwhelming' efficacy evidence for its experimental drug used to treat hospitalized Covid-19 patients.It will meet with the Food and Drug Administration to seek emergency use authorization for the treatment.
On December 13, Veru (VERU.US) surged 14.88% in pre-market trading to $7.18. Market news previously indicated that Veru's benign prostatic hyperplasia treatment drug ENTADFI received approval from the U.S. Food and Drug Administration.
This company frequently comes out with new drug developments. Last time, I even took a position, thinking that the market for male-related diseases should be quite large.![]()
BUT still lost money.
Two-pronged approach:A. The drug really works, leading to continued hype; B. The drug doesn't work, and it's just market sentiment being traded, especially given how poor the broader market is right now., and trade some speculative stocks.
$Veru Inc (VERU.US)$
A or B?
On December 13, Veru (VERU.US) surged 14.88% in pre-market trading to $7.18. Market news previously indicated that Veru's benign prostatic hyperplasia treatment drug ENTADFI received approval from the U.S. Food and Drug Administration.
This company frequently comes out with new drug developments. Last time, I even took a position, thinking that the market for male-related diseases should be quite large.
Two-pronged approach:A. The drug really works, leading to continued hype; B. The drug doesn't work, and it's just market sentiment being traded, especially given how poor the broader market is right now., and trade some speculative stocks.
$Veru Inc (VERU.US)$
A or B?
17
3
34
Unlock Pro Investors’ Money-Making Secrets
Join Futubull Community! Now Connect Directly with Top Investors & Public Company Executives